MDGL
#809
Madrigal Pharmaceuticals, Inc. - Common Stock
531.0 0 USD
-0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.06%
Changement Mensuel
+10.63%
Evolution sur 6 mois
+5.43%
Changement Annuel
+25.35%
Clôture Précédente
536.7 0
Open
531.0 0
Low
531.0 0
High
531.0 0
Volume
105
Financials
- Market Capitalization 12.24 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-45.32
ratio cours/chiffre d'affaires
13.63
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 711 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 236.97 USD | -2.81% | -2.83% | +2.78% | +69.26% | 14.87 B USD | ||
| 731 |  EXEL Exelixis, Inc. - Common Stock | 56.04 USD | -0.81% | -0.21% | +5.14% | +43.55% | 14.09 B USD | ||
| 823 |  SMMT Summit Therapeutics Inc. - Common Stock | 15.30 USD | +0.33% | -4.20% | +5.96% | -22.96% | 11.88 B USD | ||
| 828 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 228.28 USD | -2.36% | -5.79% | -10.25% | +75.33% | 11.75 B USD |